BCL11A - BCL11 transcription factor A Gene
Also Known as EVI9; CTIP1; DILOS; ZNF856; HBFQTL5; SMARCM1
Species: Homo sapiens
About BCL11A
This gene has 27 transcripts (splice variants), 212 orthologues, 14 paralogues and is associated with 79 phenotypes. Broad expression in skin (RPKM 2.8), lymph node (RPKM 2.2) and 17 other tissues.
Summary
This gene encodes a C2H2 type zinc-finger protein by its similarity to the mouse Bcl11a/Evi9 protein. The corresponding mouse gene is a common site of retroviral integration in myeloid leukemia, and may function as a leukemia disease gene, in part, through its interaction with BCL6. During hematopoietic cell differentiation, this gene is down-regulated. It is possibly involved in lymphoma pathogenesis since translocations associated with B-cell malignancies also deregulates its expression. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
BCL11A Products (34)
| mRNA | Protein | Name |
|---|---|---|
| NM_001363864.1 | NP_001350793.1 | B-cell lymphoma/leukemia 11A isoform 4 |
| NM_001365609.1 | NP_001352538.1 | B-cell lymphoma/leukemia 11A isoform 5 |
| NM_001405708.1 | NP_001392637.1 | B-cell lymphoma/leukemia 11A isoform 1 |
| NM_001405709.1 | NP_001392638.1 | B-cell lymphoma/leukemia 11A isoform 1 |
| NM_001405710.1 | NP_001392639.1 | B-cell lymphoma/leukemia 11A isoform 6 |
| NM_001405711.1 | NP_001392640.1 | B-cell lymphoma/leukemia 11A isoform 5 |
| NM_001405712.1 | NP_001392641.1 | B-cell lymphoma/leukemia 11A isoform 5 |
| NM_001405713.1 | NP_001392642.1 | B-cell lymphoma/leukemia 11A isoform 15 |
| NM_001405714.1 | NP_001392643.1 | B-cell lymphoma/leukemia 11A isoform 15 |
| NM_001405715.1 | NP_001392644.1 | B-cell lymphoma/leukemia 11A isoform 15 |
| NM_001405716.1 | NP_001392645.1 | B-cell lymphoma/leukemia 11A isoform 7 |
| NM_001405717.1 | NP_001392646.1 | B-cell lymphoma/leukemia 11A isoform 16 |
| NM_001405718.1 | NP_001392647.1 | B-cell lymphoma/leukemia 11A isoform 16 |
| NM_001405719.1 | NP_001392648.1 | B-cell lymphoma/leukemia 11A isoform 8 |
| NM_001405720.1 | NP_001392649.1 | B-cell lymphoma/leukemia 11A isoform 17 |
| NM_001405721.1 | NP_001392650.1 | B-cell lymphoma/leukemia 11A isoform 17 |
| NM_001405722.1 | NP_001392651.1 | B-cell lymphoma/leukemia 11A isoform 18 |
| NM_001405723.1 | NP_001392652.1 | B-cell lymphoma/leukemia 11A isoform 18 |
| NM_001405724.1 | NP_001392653.1 | B-cell lymphoma/leukemia 11A isoform 9 |
| NM_001405725.1 | NP_001392654.1 | B-cell lymphoma/leukemia 11A isoform 19 |
| NM_001405726.1 | NP_001392655.1 | B-cell lymphoma/leukemia 11A isoform 19 |
| NM_001405727.1 | NP_001392656.1 | B-cell lymphoma/leukemia 11A isoform 19 |
| NM_001405728.1 | NP_001392657.1 | B-cell lymphoma/leukemia 11A isoform 19 |
| NM_001405729.1 | NP_001392658.1 | B-cell lymphoma/leukemia 11A isoform 10 |
| NM_001405730.1 | NP_001392659.1 | B-cell lymphoma/leukemia 11A isoform 11 |
| NM_001405731.1 | NP_001392660.1 | B-cell lymphoma/leukemia 11A isoform 12 |
| NM_001405732.1 | NP_001392661.1 | B-cell lymphoma/leukemia 11A isoform 3 |
| NM_001405733.1 | NP_001392662.1 | B-cell lymphoma/leukemia 11A isoform 13 |
| NM_001405734.1 | NP_001392663.1 | B-cell lymphoma/leukemia 11A isoform 20 |
| NM_001405735.1 | NP_001392664.1 | B-cell lymphoma/leukemia 11A isoform 20 |
| NM_001405736.1 | NP_001392665.1 | B-cell lymphoma/leukemia 11A isoform 14 |
| NM_018014.4 | NP_060484.2 | B-cell lymphoma/leukemia 11A isoform 2 |
| NM_022893.4 | NP_075044.2 | B-cell lymphoma/leukemia 11A isoform 1 |
| NM_138559.2 | NP_612569.1 | B-cell lymphoma/leukemia 11A isoform 3 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables DNA-binding transcription factor binding |
IPI
IPI: Inferred from physical interaction
|
16704730 | GOA |
| enables DNA-binding transcription repressor activity, RNA polymerase II-specific |
IDA
IDA: Inferred from direct assay
|
16704730 | GOA |
| enables RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IDA
IDA: Inferred from direct assay
|
19153051 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
25416956 | GOA |
| enables protein heterodimerization activity |
IPI
IPI: Inferred from physical interaction
|
19616629 | GOA |
| enables protein homodimerization activity |
IPI
IPI: Inferred from physical interaction
|
16704730 | GOA |
| enables transcription coregulator activity |
IDA
IDA: Inferred from direct assay
|
29606353 | GOA |
| enables transcription regulatory region nucleic acid binding |
IDA
IDA: Inferred from direct assay
|
29606353 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in negative regulation of collateral sprouting |
IMP
IMP: Inferred from mutant phenotype
|
19616629 | GOA |
| involved in negative regulation of dendrite development |
IMP
IMP: Inferred from mutant phenotype
|
19616629 | GOA |
| involved in negative regulation of neuron projection development |
IDA
IDA: Inferred from direct assay
|
19616629 | GOA |
| involved in negative regulation of transcription by RNA polymerase II |
IDA
IDA: Inferred from direct assay
|
16704730 | GOA |
| involved in positive regulation of collateral sprouting |
IMP
IMP: Inferred from mutant phenotype
|
19616629 | GOA |
| involved in positive regulation of neuron projection development |
IDA
IDA: Inferred from direct assay
|
19616629 | GOA |
| involved in regulation of dendrite development |
IMP
IMP: Inferred from mutant phenotype
|
19616629 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| part of SWI/SNF complex |
IDA
IDA: Inferred from direct assay
|
23644491 | GOA |
| located in nucleus |
IDA
IDA: Inferred from direct assay
|
19616629 | GOA |
| located in paraspeckles |
IDA
IDA: Inferred from direct assay
|
16704730 | GOA |
BCL11A Protein Structure
zf-C2H2_6: C2H2-type zinc finger (46 - 72)
zf-H2C2_2: Zinc-finger double domain (391 - 415)
zf-H2C2_2: Zinc-finger double domain (756 - 780)
zf-C2H2: Zinc finger, C2H2 type (800 - 823)
- 0
- 200
- 400
- 600
- 835 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
B-cell lymphoma/leukemia 11A |
|
BCL11A Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P80094 | Ctip1 Antibody (YA489) | WB, FC, ICC/IF | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Intellectual Developmental Disorder With Persistence Of Fetal Hemoglobin |
|
|
| Hereditary Persistence Of Fetal Hemoglobin-Intellectual Disability Syndrome |
|
|
| Corpus Callosum, Agenesis Of |
|
|
| Intellectual Disability - Hypoplastic Corpus Callosum - Preauricular Tag |
|
|
| Polydactyly, Postaxial, Type A1 |
|
|
| Fetal Hemoglobin Quantitative Trait Locus 5 |
|
|
| Bcl11a-Related Intellectual Disability |
|
|
| Hereditary Persistence Of Fetal Hemoglobin-Sickle Cell Disease Syndrome |
|
|
| B-Cell Lymphoma |
|
|
| Lymphoma |
|
|
| Cerebellar Hypoplasia/Atrophy, Epilepsy, And Global Developmental Delay |
|
|
| Sickle Cell Anemia |
|
|
| Leukemia |
|
|
| Microcephaly |
|
|
| Thalassemia |
|
|
| Beta-Thalassemia |
|
|
| Blood Protein Disease |
|
|
| Chromosome 2p16.1-P15 Deletion Syndrome |
|
|
| Beta-Thalassemia Major |
|
|
| Congenital Hemolytic Anemia |
|
|
| Peroxisome Biogenesis Disorder 11a |
|
|
| Fetal Hemoglobin Quantitative Trait Locus 1 |
|
|
| Beta-Thalassemia Intermedia |
|
|
| Hemoglobinopathy |
|
|
| Mediastinal Gray Zone Lymphoma |
|
|
| Mediastinal Malignant Lymphoma |
|
|
| Hemoglobin E Disease |
|
|
| Anemia, Congenital Dyserythropoietic, Type Iv |
|
|
| Acute Chest Syndrome |
|
|
| Hemoglobin C Disease |
|
|
| Priapism |
|
|
| Prion Disease |
|
|
| Alpha-Thalassemia |
|
|
| Autosomal Dominant Beta Thalassemia |
|
|
| Penile Disease |
|
|
| Patau Syndrome |
|
|
| Granulomatous Disease, Chronic, X-Linked |
|
|
| Hemolytic Anemia |
|
|
| Strabismus |
|
|
| Hemoglobin H Disease |
|
|
| Autism |
|
|
| Deficiency Anemia |
|
|
| Leber Plus Disease |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Canis familiaris | BCL11A | VGNC | VGNC:58661 |
| Rattus norvegicus | BCL11A | RGD | RGD:1309923 |
| Felis catus | BCL11A | VGNC | VGNC:60083 |
| Bos taurus | BCL11A | VGNC | VGNC:59205 |
| Macaca mulatta | BCL11A | VGNC | VGNC:70055 |
| Mus musculus | BCL11A | MGD | MGI:106190 |
| Others | BCL11A | NCBI |